6Marchesini G, Brizi M, Bianchi G, et al. Nonalcoholic fatter liver disease :a feature of the metabolic syndrome [ J ]. Diabetes,2001,50 (8) : 1844-1850.
7Zamora-Valdes D, Chavez-Tapia NC, Mendez-Sanehez N. Molecular mechanisms of insulin resistance[ J ]. Med Sur, 2004, 11 (3) : 149- 159.
8Liu YF, Herschkovitz A, Boura-Halfon S, et al. Serine phosphorylation proximal to its phosphotyrosine binding domain inhibits insulin receptor substrate 1 function and promotes insulin resistance[ J ]. Mol Cell Biol, 2004,24 ( 21 ) :9668-9681.
9Donnelly KL, Smith CI, Schwarzenberg S J, et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease [ J ]. J Clin Invest, 2005, 115 ( 5 ) : 1343-1351.
10Barazzoni R, Bosutti A, Stebel M, et al. Ghrelin regulates mitoehondrial-lipid metabolism gene expression and tissue fat distribution in liver and skeletal muscle [ J ]. Am J Physiol Endocrinol Metab, 2005, 288( 1 ) : E228-235.
二级参考文献23
1Sorrentino P, Tarantino G, Conca P, et al. Silent non-alcoholic fatty liver disease: a clinical histological study. J Hepatol, 2004,41:751-757.
2Seidell JC. Obesity, insulin resistance and diabetes-a world wide epidemic. Br J Nutr, 2000, 83(Suppl 1): S5-8.
4Omagari K, Kadokawa Y, Masuda J, et al. Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics. Gastroenterol Hepatol, 2002, 17: 1098-1105.
5Choudhury J, Sanyal AJ. Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease. Clin liver Dis, 2004, 8: 575-594.
6Day CP. The potential role of gene in nonalcoholic fatty liver disease. Clin liver Dis, 2004, 8: 673-691.
7Bradbury MW, Berk PD. Lipid metabolism in hepatic steatosis. Clin liver Dis, 2004, 8: 639-671.
8Feldstein A, Gores GJ. Steatohepatitis and apoptosis: therapeutic implications. Am J Gastroenterol, 2004, 99: 1718-1719.
9Pessayre D, Fromenty B, Mansouri A. Mitochondrial injury in steatohepatitis. Eur J Gastroenterol Hepatol, 2004, 16: 1095-1105.
10Lopez-Bermejo A, Botas P, Funahashi T, et al. Adiponectin, hepatocellular dysfunction and insulin sensitivity. Clin Endocrinol, 2004,60: 256-263.
4Guo-Qing Hou~1 Xiu-Ling Liang~2 Rong Chen~2 Li-Wen Tang~3 Ying Wang~2 Ping-Yi Xu~2 Ying-Ru Zhang~2 Cui-Hua Ou~2 1 Department of Neurology.Guangzhou First Municipal People’s Hospital,Guangzhou Medical College,Guangzhou 510180,Guangdong Province.China2 Department of Neurology.First Affiliated Hospital.Sun Yat-Sen University of Medical Sciences.Guangzhou 510080.Guangdong Province.China3 Department of Pharmacology,University of Kentucky.Lexington,KY 40506.USA.Copper transportion of WD protein in hepatocytes from Wilson disease patients in vitro[J].World Journal of Gastroenterology,2001,7(6):846-851. 被引量：4
